Global Constipation Treatment Drug Market
Global Constipation Treatment Drug Market

Constipation Treatment Drug Comprehensive Study by Type (Laxatives, Chloride Channel Activators, 5-HT4 Receptor Agonists, GC-C Agonists, Peripherally Acting Mu-Opioid Receptor Antagonists), Application (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Diseases Type (Chronic idiopathic constipation (CIC), Irritable bowel syndrome with constipation (IBS-C), Opioid-induced constipation (OIC)), Route of administration (Oral, Parenteral) Players and Region - Global Market Outlook to 2024

Constipation Treatment Drug Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 237 Pages 192 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Constipation Treatment Drug Market Scope
Constipation Treatment Drug helps to get instant relief from the constipation problems. This problem is referred to the indigested food which is infrequent or hard to pass through the body. It causes lots of complication such as hemorrhoids, abdominal pain, etc. Treatments for these diseases depends on various factors such as the duration from which a person is suffering from this problem. It is seen that the general population rates of constipation are up to 2 -30 percentage. In which the elderly people living in old age has the rate of constipation up to 50-75 percent.

The market study is being classified by Type (Laxatives, Chloride Channel Activators, 5-HT4 Receptor Agonists, GC-C Agonists and Peripherally Acting Mu-Opioid Receptor Antagonists), by Application (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) and major geographies with country level break-up.

Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Constipation Treatment Drug market throughout the predicted period.

AstraZeneca (United Kingdom), Bayer AG (Germany), Sanofi (France), Sucampo Pharmaceuticals, Inc. (United States), Takeda Pharmaceuticals Company Limited (India), Ironwood Pharmaceuticals, Inc. (United States), Bausch Health (Canada), Abbott Laboratories (United States), Cosmo Pharmaceuticals NV (Ireland) and Synergy Pharmaceuticals, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Prestige Brands Holdings, Inc. (United States), Janssen Pharmaceutical Company (Belgium) and Shionogi & Co., Ltd. (Japan).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Constipation Treatment Drug market by Type, Application and Region.

On the basis of geography, the market of Constipation Treatment Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Diseases Type, the sub-segment i.e. Chronic idiopathic constipation (CIC) will boost the Constipation Treatment Drug market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Route of administration, the sub-segment i.e. Oral will boost the Constipation Treatment Drug market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

On 29th November 2018, EA Pharma Co., Ltd., Eisai Co., Ltd., Mochida Pharmaceutical Co., Ltd. launched a drug for constipation treatment known as MOVICOL. It is the first polyethylene glycol preparation for Chronic Constipation in Japan.


Market Trend
  • Industry Players are Making a High Trend by Investing in Development of Novel Specialty Constipation Treatment

Market Drivers
  • The Pervasiveness of IBS-C, OIC, and Chronic Constipation among People
  • Increasing Habits of Eating Junk Food
  • Rising Geriatric Population

Opportunities
  • Emerging Economies Opening New Opportunities for Market
  • Growing Incidences of Functional Constipation across the Globe

Restraints
  • Popularity Of Over the Counter (OTD) Drugs Has Restrains the Market

Challenges
  • Availability of Alternative Substitutes Present Such as Home Remedies
  • Low Awareness Regarding Diagnosis and Treatment Methods for Chronic Idiopathic Constipation


Key Target Audience
Drug Manufacturers, Drug Suppliers, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Potential Investors

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Laxatives
  • Chloride Channel Activators
  • 5-HT4 Receptor Agonists
  • GC-C Agonists
  • Peripherally Acting Mu-Opioid Receptor Antagonists
By Application
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Diseases Type
  • Chronic idiopathic constipation (CIC)
  • Irritable bowel syndrome with constipation (IBS-C)
  • Opioid-induced constipation (OIC)

By Route of administration
  • Oral
  • Parenteral

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Pervasiveness of IBS-C, OIC, and Chronic Constipation among People
      • 3.2.2. Increasing Habits of Eating Junk Food
      • 3.2.3. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Substitutes Present Such as Home Remedies
      • 3.3.2. Low Awareness Regarding Diagnosis and Treatment Methods for Chronic Idiopathic Constipation
    • 3.4. Market Trends
      • 3.4.1. Industry Players are Making a High Trend by Investing in Development of Novel Specialty Constipation Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Constipation Treatment Drug, by Type, Application, Diseases Type, Route of administration and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Constipation Treatment Drug (Value)
      • 5.2.1. Global Constipation Treatment Drug by: Type (Value)
        • 5.2.1.1. Laxatives
        • 5.2.1.2. Chloride Channel Activators
        • 5.2.1.3. 5-HT4 Receptor Agonists
        • 5.2.1.4. GC-C Agonists
        • 5.2.1.5. Peripherally Acting Mu-Opioid Receptor Antagonists
      • 5.2.2. Global Constipation Treatment Drug by: Application (Value)
        • 5.2.2.1. Retail Pharmacies
        • 5.2.2.2. Hospital Pharmacies
        • 5.2.2.3. Online Pharmacies
      • 5.2.3. Global Constipation Treatment Drug by: Diseases Type (Value)
        • 5.2.3.1. Chronic idiopathic constipation (CIC)
        • 5.2.3.2. Irritable bowel syndrome with constipation (IBS-C)
        • 5.2.3.3. Opioid-induced constipation (OIC)
      • 5.2.4. Global Constipation Treatment Drug by: Route of administration (Value)
        • 5.2.4.1. Oral
        • 5.2.4.2. Parenteral
      • 5.2.5. Global Constipation Treatment Drug Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Constipation Treatment Drug (Volume)
      • 5.3.1. Global Constipation Treatment Drug by: Type (Volume)
        • 5.3.1.1. Laxatives
        • 5.3.1.2. Chloride Channel Activators
        • 5.3.1.3. 5-HT4 Receptor Agonists
        • 5.3.1.4. GC-C Agonists
        • 5.3.1.5. Peripherally Acting Mu-Opioid Receptor Antagonists
      • 5.3.2. Global Constipation Treatment Drug by: Application (Volume)
        • 5.3.2.1. Retail Pharmacies
        • 5.3.2.2. Hospital Pharmacies
        • 5.3.2.3. Online Pharmacies
      • 5.3.3. Global Constipation Treatment Drug by: Diseases Type (Volume)
        • 5.3.3.1. Chronic idiopathic constipation (CIC)
        • 5.3.3.2. Irritable bowel syndrome with constipation (IBS-C)
        • 5.3.3.3. Opioid-induced constipation (OIC)
      • 5.3.4. Global Constipation Treatment Drug by: Route of administration (Volume)
        • 5.3.4.1. Oral
        • 5.3.4.2. Parenteral
      • 5.3.5. Global Constipation Treatment Drug Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Constipation Treatment Drug (Price)
      • 5.4.1. Global Constipation Treatment Drug by: Type (Price)
  • 6. Constipation Treatment Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AstraZeneca (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sanofi (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sucampo Pharmaceuticals, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Takeda Pharmaceuticals Company Limited (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ironwood Pharmaceuticals, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bausch Health (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Abbott Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cosmo Pharmaceuticals NV (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Synergy Pharmaceuticals, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Constipation Treatment Drug Sale, by Type, Application, Diseases Type, Route of administration and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Constipation Treatment Drug (Value)
      • 7.2.1. Global Constipation Treatment Drug by: Type (Value)
        • 7.2.1.1. Laxatives
        • 7.2.1.2. Chloride Channel Activators
        • 7.2.1.3. 5-HT4 Receptor Agonists
        • 7.2.1.4. GC-C Agonists
        • 7.2.1.5. Peripherally Acting Mu-Opioid Receptor Antagonists
      • 7.2.2. Global Constipation Treatment Drug by: Application (Value)
        • 7.2.2.1. Retail Pharmacies
        • 7.2.2.2. Hospital Pharmacies
        • 7.2.2.3. Online Pharmacies
      • 7.2.3. Global Constipation Treatment Drug by: Diseases Type (Value)
        • 7.2.3.1. Chronic idiopathic constipation (CIC)
        • 7.2.3.2. Irritable bowel syndrome with constipation (IBS-C)
        • 7.2.3.3. Opioid-induced constipation (OIC)
      • 7.2.4. Global Constipation Treatment Drug by: Route of administration (Value)
        • 7.2.4.1. Oral
        • 7.2.4.2. Parenteral
      • 7.2.5. Global Constipation Treatment Drug Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Constipation Treatment Drug (Volume)
      • 7.3.1. Global Constipation Treatment Drug by: Type (Volume)
        • 7.3.1.1. Laxatives
        • 7.3.1.2. Chloride Channel Activators
        • 7.3.1.3. 5-HT4 Receptor Agonists
        • 7.3.1.4. GC-C Agonists
        • 7.3.1.5. Peripherally Acting Mu-Opioid Receptor Antagonists
      • 7.3.2. Global Constipation Treatment Drug by: Application (Volume)
        • 7.3.2.1. Retail Pharmacies
        • 7.3.2.2. Hospital Pharmacies
        • 7.3.2.3. Online Pharmacies
      • 7.3.3. Global Constipation Treatment Drug by: Diseases Type (Volume)
        • 7.3.3.1. Chronic idiopathic constipation (CIC)
        • 7.3.3.2. Irritable bowel syndrome with constipation (IBS-C)
        • 7.3.3.3. Opioid-induced constipation (OIC)
      • 7.3.4. Global Constipation Treatment Drug by: Route of administration (Volume)
        • 7.3.4.1. Oral
        • 7.3.4.2. Parenteral
      • 7.3.5. Global Constipation Treatment Drug Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Constipation Treatment Drug (Price)
      • 7.4.1. Global Constipation Treatment Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Constipation Treatment Drug: by Type(USD Million)
  • Table 2. Constipation Treatment Drug Laxatives , by Region USD Million (2013-2018)
  • Table 3. Constipation Treatment Drug Chloride Channel Activators , by Region USD Million (2013-2018)
  • Table 4. Constipation Treatment Drug 5-HT4 Receptor Agonists , by Region USD Million (2013-2018)
  • Table 5. Constipation Treatment Drug GC-C Agonists , by Region USD Million (2013-2018)
  • Table 6. Constipation Treatment Drug Peripherally Acting Mu-Opioid Receptor Antagonists , by Region USD Million (2013-2018)
  • Table 7. Constipation Treatment Drug: by Application(USD Million)
  • Table 8. Constipation Treatment Drug Retail Pharmacies , by Region USD Million (2013-2018)
  • Table 9. Constipation Treatment Drug Hospital Pharmacies , by Region USD Million (2013-2018)
  • Table 10. Constipation Treatment Drug Online Pharmacies , by Region USD Million (2013-2018)
  • Table 11. Constipation Treatment Drug: by Diseases Type(USD Million)
  • Table 12. Constipation Treatment Drug Chronic idiopathic constipation (CIC) , by Region USD Million (2013-2018)
  • Table 13. Constipation Treatment Drug Irritable bowel syndrome with constipation (IBS-C) , by Region USD Million (2013-2018)
  • Table 14. Constipation Treatment Drug Opioid-induced constipation (OIC) , by Region USD Million (2013-2018)
  • Table 15. Constipation Treatment Drug: by Route of administration(USD Million)
  • Table 16. Constipation Treatment Drug Oral , by Region USD Million (2013-2018)
  • Table 17. Constipation Treatment Drug Parenteral , by Region USD Million (2013-2018)
  • Table 18. South America Constipation Treatment Drug, by Country USD Million (2013-2018)
  • Table 19. South America Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 20. South America Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 21. South America Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 22. South America Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 23. Brazil Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 24. Brazil Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 25. Brazil Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 26. Brazil Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 27. Argentina Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 28. Argentina Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 29. Argentina Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 30. Argentina Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 31. Rest of South America Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 32. Rest of South America Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 33. Rest of South America Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 34. Rest of South America Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 35. Asia Pacific Constipation Treatment Drug, by Country USD Million (2013-2018)
  • Table 36. Asia Pacific Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 37. Asia Pacific Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 38. Asia Pacific Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 39. Asia Pacific Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 40. China Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 41. China Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 42. China Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 43. China Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 44. Japan Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 45. Japan Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 46. Japan Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 47. Japan Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 48. India Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 49. India Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 50. India Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 51. India Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 52. South Korea Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 53. South Korea Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 54. South Korea Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 55. South Korea Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 56. Taiwan Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 57. Taiwan Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 58. Taiwan Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 59. Taiwan Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 60. Australia Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 61. Australia Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 62. Australia Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 63. Australia Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 64. Rest of Asia-Pacific Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 65. Rest of Asia-Pacific Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 68. Europe Constipation Treatment Drug, by Country USD Million (2013-2018)
  • Table 69. Europe Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 70. Europe Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 71. Europe Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 72. Europe Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 73. Germany Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 74. Germany Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 75. Germany Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 76. Germany Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 77. France Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 78. France Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 79. France Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 80. France Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 81. Italy Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 82. Italy Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 83. Italy Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 84. Italy Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 85. United Kingdom Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 86. United Kingdom Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 87. United Kingdom Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 88. United Kingdom Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 89. Netherlands Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 90. Netherlands Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 91. Netherlands Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 92. Netherlands Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 93. Rest of Europe Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 94. Rest of Europe Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 95. Rest of Europe Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 96. Rest of Europe Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 97. MEA Constipation Treatment Drug, by Country USD Million (2013-2018)
  • Table 98. MEA Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 99. MEA Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 100. MEA Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 101. MEA Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 102. Middle East Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 103. Middle East Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 104. Middle East Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 105. Middle East Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 106. Africa Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 107. Africa Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 108. Africa Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 109. Africa Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 110. North America Constipation Treatment Drug, by Country USD Million (2013-2018)
  • Table 111. North America Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 112. North America Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 113. North America Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 114. North America Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 115. United States Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 116. United States Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 117. United States Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 118. United States Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 119. Canada Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 120. Canada Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 121. Canada Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 122. Canada Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 123. Mexico Constipation Treatment Drug, by Type USD Million (2013-2018)
  • Table 124. Mexico Constipation Treatment Drug, by Application USD Million (2013-2018)
  • Table 125. Mexico Constipation Treatment Drug, by Diseases Type USD Million (2013-2018)
  • Table 126. Mexico Constipation Treatment Drug, by Route of administration USD Million (2013-2018)
  • Table 127. Constipation Treatment Drug Sales: by Type(unit)
  • Table 128. Constipation Treatment Drug Sales Laxatives , by Region unit (2013-2018)
  • Table 129. Constipation Treatment Drug Sales Chloride Channel Activators , by Region unit (2013-2018)
  • Table 130. Constipation Treatment Drug Sales 5-HT4 Receptor Agonists , by Region unit (2013-2018)
  • Table 131. Constipation Treatment Drug Sales GC-C Agonists , by Region unit (2013-2018)
  • Table 132. Constipation Treatment Drug Sales Peripherally Acting Mu-Opioid Receptor Antagonists , by Region unit (2013-2018)
  • Table 133. Constipation Treatment Drug Sales: by Application(unit)
  • Table 134. Constipation Treatment Drug Sales Retail Pharmacies , by Region unit (2013-2018)
  • Table 135. Constipation Treatment Drug Sales Hospital Pharmacies , by Region unit (2013-2018)
  • Table 136. Constipation Treatment Drug Sales Online Pharmacies , by Region unit (2013-2018)
  • Table 137. Constipation Treatment Drug Sales: by Diseases Type(unit)
  • Table 138. Constipation Treatment Drug Sales Chronic idiopathic constipation (CIC) , by Region unit (2013-2018)
  • Table 139. Constipation Treatment Drug Sales Irritable bowel syndrome with constipation (IBS-C) , by Region unit (2013-2018)
  • Table 140. Constipation Treatment Drug Sales Opioid-induced constipation (OIC) , by Region unit (2013-2018)
  • Table 141. Constipation Treatment Drug Sales: by Route of administration(unit)
  • Table 142. Constipation Treatment Drug Sales Oral , by Region unit (2013-2018)
  • Table 143. Constipation Treatment Drug Sales Parenteral , by Region unit (2013-2018)
  • Table 144. South America Constipation Treatment Drug Sales, by Country unit (2013-2018)
  • Table 145. South America Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 146. South America Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 147. South America Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 148. South America Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 149. Brazil Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 150. Brazil Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 151. Brazil Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 152. Brazil Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 153. Argentina Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 154. Argentina Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 155. Argentina Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 156. Argentina Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 157. Rest of South America Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 158. Rest of South America Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 159. Rest of South America Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 160. Rest of South America Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 161. Asia Pacific Constipation Treatment Drug Sales, by Country unit (2013-2018)
  • Table 162. Asia Pacific Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 163. Asia Pacific Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 164. Asia Pacific Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 165. Asia Pacific Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 166. China Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 167. China Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 168. China Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 169. China Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 170. Japan Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 171. Japan Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 172. Japan Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 173. Japan Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 174. India Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 175. India Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 176. India Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 177. India Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 178. South Korea Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 179. South Korea Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 180. South Korea Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 181. South Korea Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 182. Taiwan Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 183. Taiwan Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 184. Taiwan Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 185. Taiwan Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 186. Australia Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 187. Australia Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 188. Australia Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 189. Australia Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 190. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 191. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 192. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 193. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 194. Europe Constipation Treatment Drug Sales, by Country unit (2013-2018)
  • Table 195. Europe Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 196. Europe Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 197. Europe Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 198. Europe Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 199. Germany Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 200. Germany Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 201. Germany Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 202. Germany Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 203. France Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 204. France Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 205. France Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 206. France Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 207. Italy Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 208. Italy Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 209. Italy Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 210. Italy Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 211. United Kingdom Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 212. United Kingdom Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 213. United Kingdom Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 214. United Kingdom Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 215. Netherlands Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 216. Netherlands Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 217. Netherlands Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 218. Netherlands Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 219. Rest of Europe Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 220. Rest of Europe Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 221. Rest of Europe Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 222. Rest of Europe Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 223. MEA Constipation Treatment Drug Sales, by Country unit (2013-2018)
  • Table 224. MEA Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 225. MEA Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 226. MEA Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 227. MEA Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 228. Middle East Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 229. Middle East Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 230. Middle East Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 231. Middle East Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 232. Africa Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 233. Africa Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 234. Africa Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 235. Africa Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 236. North America Constipation Treatment Drug Sales, by Country unit (2013-2018)
  • Table 237. North America Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 238. North America Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 239. North America Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 240. North America Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 241. United States Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 242. United States Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 243. United States Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 244. United States Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 245. Canada Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 246. Canada Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 247. Canada Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 248. Canada Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 249. Mexico Constipation Treatment Drug Sales, by Type unit (2013-2018)
  • Table 250. Mexico Constipation Treatment Drug Sales, by Application unit (2013-2018)
  • Table 251. Mexico Constipation Treatment Drug Sales, by Diseases Type unit (2013-2018)
  • Table 252. Mexico Constipation Treatment Drug Sales, by Route of administration unit (2013-2018)
  • Table 253. Constipation Treatment Drug: by Type(USD/Units)
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Constipation Treatment Drug: by Type(USD Million)
  • Table 265. Constipation Treatment Drug Laxatives , by Region USD Million (2019-2024)
  • Table 266. Constipation Treatment Drug Chloride Channel Activators , by Region USD Million (2019-2024)
  • Table 267. Constipation Treatment Drug 5-HT4 Receptor Agonists , by Region USD Million (2019-2024)
  • Table 268. Constipation Treatment Drug GC-C Agonists , by Region USD Million (2019-2024)
  • Table 269. Constipation Treatment Drug Peripherally Acting Mu-Opioid Receptor Antagonists , by Region USD Million (2019-2024)
  • Table 270. Constipation Treatment Drug: by Application(USD Million)
  • Table 271. Constipation Treatment Drug Retail Pharmacies , by Region USD Million (2019-2024)
  • Table 272. Constipation Treatment Drug Hospital Pharmacies , by Region USD Million (2019-2024)
  • Table 273. Constipation Treatment Drug Online Pharmacies , by Region USD Million (2019-2024)
  • Table 274. Constipation Treatment Drug: by Diseases Type(USD Million)
  • Table 275. Constipation Treatment Drug Chronic idiopathic constipation (CIC) , by Region USD Million (2019-2024)
  • Table 276. Constipation Treatment Drug Irritable bowel syndrome with constipation (IBS-C) , by Region USD Million (2019-2024)
  • Table 277. Constipation Treatment Drug Opioid-induced constipation (OIC) , by Region USD Million (2019-2024)
  • Table 278. Constipation Treatment Drug: by Route of administration(USD Million)
  • Table 279. Constipation Treatment Drug Oral , by Region USD Million (2019-2024)
  • Table 280. Constipation Treatment Drug Parenteral , by Region USD Million (2019-2024)
  • Table 281. South America Constipation Treatment Drug, by Country USD Million (2019-2024)
  • Table 282. South America Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 283. South America Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 284. South America Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 285. South America Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 286. Brazil Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 287. Brazil Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 288. Brazil Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 289. Brazil Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 290. Argentina Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 291. Argentina Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 292. Argentina Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 293. Argentina Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 294. Rest of South America Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 295. Rest of South America Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 296. Rest of South America Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 297. Rest of South America Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 298. Asia Pacific Constipation Treatment Drug, by Country USD Million (2019-2024)
  • Table 299. Asia Pacific Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 300. Asia Pacific Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 301. Asia Pacific Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 302. Asia Pacific Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 303. China Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 304. China Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 305. China Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 306. China Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 307. Japan Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 308. Japan Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 309. Japan Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 310. Japan Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 311. India Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 312. India Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 313. India Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 314. India Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 315. South Korea Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 316. South Korea Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 317. South Korea Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 318. South Korea Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 319. Taiwan Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 320. Taiwan Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 321. Taiwan Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 322. Taiwan Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 323. Australia Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 324. Australia Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 325. Australia Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 326. Australia Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 327. Rest of Asia-Pacific Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 328. Rest of Asia-Pacific Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 329. Rest of Asia-Pacific Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 330. Rest of Asia-Pacific Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 331. Europe Constipation Treatment Drug, by Country USD Million (2019-2024)
  • Table 332. Europe Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 333. Europe Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 334. Europe Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 335. Europe Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 336. Germany Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 337. Germany Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 338. Germany Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 339. Germany Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 340. France Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 341. France Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 342. France Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 343. France Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 344. Italy Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 345. Italy Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 346. Italy Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 347. Italy Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 348. United Kingdom Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 349. United Kingdom Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 350. United Kingdom Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 351. United Kingdom Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 352. Netherlands Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 353. Netherlands Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 354. Netherlands Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 355. Netherlands Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 356. Rest of Europe Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 357. Rest of Europe Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 358. Rest of Europe Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 359. Rest of Europe Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 360. MEA Constipation Treatment Drug, by Country USD Million (2019-2024)
  • Table 361. MEA Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 362. MEA Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 363. MEA Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 364. MEA Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 365. Middle East Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 366. Middle East Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 367. Middle East Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 368. Middle East Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 369. Africa Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 370. Africa Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 371. Africa Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 372. Africa Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 373. North America Constipation Treatment Drug, by Country USD Million (2019-2024)
  • Table 374. North America Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 375. North America Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 376. North America Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 377. North America Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 378. United States Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 379. United States Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 380. United States Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 381. United States Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 382. Canada Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 383. Canada Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 384. Canada Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 385. Canada Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 386. Mexico Constipation Treatment Drug, by Type USD Million (2019-2024)
  • Table 387. Mexico Constipation Treatment Drug, by Application USD Million (2019-2024)
  • Table 388. Mexico Constipation Treatment Drug, by Diseases Type USD Million (2019-2024)
  • Table 389. Mexico Constipation Treatment Drug, by Route of administration USD Million (2019-2024)
  • Table 390. Constipation Treatment Drug Sales: by Type(unit)
  • Table 391. Constipation Treatment Drug Sales Laxatives , by Region unit (2019-2024)
  • Table 392. Constipation Treatment Drug Sales Chloride Channel Activators , by Region unit (2019-2024)
  • Table 393. Constipation Treatment Drug Sales 5-HT4 Receptor Agonists , by Region unit (2019-2024)
  • Table 394. Constipation Treatment Drug Sales GC-C Agonists , by Region unit (2019-2024)
  • Table 395. Constipation Treatment Drug Sales Peripherally Acting Mu-Opioid Receptor Antagonists , by Region unit (2019-2024)
  • Table 396. Constipation Treatment Drug Sales: by Application(unit)
  • Table 397. Constipation Treatment Drug Sales Retail Pharmacies , by Region unit (2019-2024)
  • Table 398. Constipation Treatment Drug Sales Hospital Pharmacies , by Region unit (2019-2024)
  • Table 399. Constipation Treatment Drug Sales Online Pharmacies , by Region unit (2019-2024)
  • Table 400. Constipation Treatment Drug Sales: by Diseases Type(unit)
  • Table 401. Constipation Treatment Drug Sales Chronic idiopathic constipation (CIC) , by Region unit (2019-2024)
  • Table 402. Constipation Treatment Drug Sales Irritable bowel syndrome with constipation (IBS-C) , by Region unit (2019-2024)
  • Table 403. Constipation Treatment Drug Sales Opioid-induced constipation (OIC) , by Region unit (2019-2024)
  • Table 404. Constipation Treatment Drug Sales: by Route of administration(unit)
  • Table 405. Constipation Treatment Drug Sales Oral , by Region unit (2019-2024)
  • Table 406. Constipation Treatment Drug Sales Parenteral , by Region unit (2019-2024)
  • Table 407. South America Constipation Treatment Drug Sales, by Country unit (2019-2024)
  • Table 408. South America Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 409. South America Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 410. South America Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 411. South America Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 412. Brazil Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 413. Brazil Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 414. Brazil Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 415. Brazil Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 416. Argentina Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 417. Argentina Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 418. Argentina Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 419. Argentina Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 420. Rest of South America Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 421. Rest of South America Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 422. Rest of South America Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 423. Rest of South America Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 424. Asia Pacific Constipation Treatment Drug Sales, by Country unit (2019-2024)
  • Table 425. Asia Pacific Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 426. Asia Pacific Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 427. Asia Pacific Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 428. Asia Pacific Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 429. China Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 430. China Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 431. China Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 432. China Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 433. Japan Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 434. Japan Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 435. Japan Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 436. Japan Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 437. India Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 438. India Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 439. India Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 440. India Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 441. South Korea Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 442. South Korea Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 443. South Korea Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 444. South Korea Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 445. Taiwan Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 446. Taiwan Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 447. Taiwan Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 448. Taiwan Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 449. Australia Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 450. Australia Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 451. Australia Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 452. Australia Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 453. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 454. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 455. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 456. Rest of Asia-Pacific Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 457. Europe Constipation Treatment Drug Sales, by Country unit (2019-2024)
  • Table 458. Europe Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 459. Europe Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 460. Europe Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 461. Europe Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 462. Germany Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 463. Germany Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 464. Germany Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 465. Germany Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 466. France Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 467. France Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 468. France Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 469. France Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 470. Italy Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 471. Italy Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 472. Italy Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 473. Italy Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 474. United Kingdom Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 475. United Kingdom Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 476. United Kingdom Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 477. United Kingdom Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 478. Netherlands Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 479. Netherlands Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 480. Netherlands Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 481. Netherlands Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 482. Rest of Europe Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 483. Rest of Europe Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 484. Rest of Europe Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 485. Rest of Europe Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 486. MEA Constipation Treatment Drug Sales, by Country unit (2019-2024)
  • Table 487. MEA Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 488. MEA Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 489. MEA Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 490. MEA Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 491. Middle East Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 492. Middle East Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 493. Middle East Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 494. Middle East Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 495. Africa Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 496. Africa Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 497. Africa Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 498. Africa Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 499. North America Constipation Treatment Drug Sales, by Country unit (2019-2024)
  • Table 500. North America Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 501. North America Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 502. North America Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 503. North America Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 504. United States Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 505. United States Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 506. United States Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 507. United States Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 508. Canada Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 509. Canada Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 510. Canada Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 511. Canada Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 512. Mexico Constipation Treatment Drug Sales, by Type unit (2019-2024)
  • Table 513. Mexico Constipation Treatment Drug Sales, by Application unit (2019-2024)
  • Table 514. Mexico Constipation Treatment Drug Sales, by Diseases Type unit (2019-2024)
  • Table 515. Mexico Constipation Treatment Drug Sales, by Route of administration unit (2019-2024)
  • Table 516. Constipation Treatment Drug: by Type(USD/Units)
  • Table 517. Research Programs/Design for This Report
  • Table 518. Key Data Information from Secondary Sources
  • Table 519. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Constipation Treatment Drug: by Type USD Million (2013-2018)
  • Figure 5. Global Constipation Treatment Drug: by Application USD Million (2013-2018)
  • Figure 6. Global Constipation Treatment Drug: by Diseases Type USD Million (2013-2018)
  • Figure 7. Global Constipation Treatment Drug: by Route of administration USD Million (2013-2018)
  • Figure 8. South America Constipation Treatment Drug Share (%), by Country
  • Figure 9. Asia Pacific Constipation Treatment Drug Share (%), by Country
  • Figure 10. Europe Constipation Treatment Drug Share (%), by Country
  • Figure 11. MEA Constipation Treatment Drug Share (%), by Country
  • Figure 12. North America Constipation Treatment Drug Share (%), by Country
  • Figure 13. Global Constipation Treatment Drug: by Type unit (2013-2018)
  • Figure 14. Global Constipation Treatment Drug: by Application unit (2013-2018)
  • Figure 15. Global Constipation Treatment Drug: by Diseases Type unit (2013-2018)
  • Figure 16. Global Constipation Treatment Drug: by Route of administration unit (2013-2018)
  • Figure 17. South America Constipation Treatment Drug Share (%), by Country
  • Figure 18. Asia Pacific Constipation Treatment Drug Share (%), by Country
  • Figure 19. Europe Constipation Treatment Drug Share (%), by Country
  • Figure 20. MEA Constipation Treatment Drug Share (%), by Country
  • Figure 21. North America Constipation Treatment Drug Share (%), by Country
  • Figure 22. Global Constipation Treatment Drug: by Type USD/Units (2013-2018)
  • Figure 23. Global Constipation Treatment Drug share by Players 2018 (%)
  • Figure 24. Global Constipation Treatment Drug share by Players (Top 3) 2018(%)
  • Figure 25. Global Constipation Treatment Drug share by Players (Top 5) 2018(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. AstraZeneca (United Kingdom) Revenue: by Geography 2018
  • Figure 29. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 31. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 32. Sanofi (France) Revenue: by Geography 2018
  • Figure 33. Sucampo Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Sucampo Pharmaceuticals, Inc. (United States) Revenue: by Geography 2018
  • Figure 35. Takeda Pharmaceuticals Company Limited (India) Revenue, Net Income and Gross profit
  • Figure 36. Takeda Pharmaceuticals Company Limited (India) Revenue: by Geography 2018
  • Figure 37. Ironwood Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Ironwood Pharmaceuticals, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. Bausch Health (Canada) Revenue, Net Income and Gross profit
  • Figure 40. Bausch Health (Canada) Revenue: by Geography 2018
  • Figure 41. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 42. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 43. Cosmo Pharmaceuticals NV (Ireland) Revenue, Net Income and Gross profit
  • Figure 44. Cosmo Pharmaceuticals NV (Ireland) Revenue: by Geography 2018
  • Figure 45. Synergy Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Synergy Pharmaceuticals, Inc. (United States) Revenue: by Geography 2018
  • Figure 47. Global Constipation Treatment Drug: by Type USD Million (2019-2024)
  • Figure 48. Global Constipation Treatment Drug: by Application USD Million (2019-2024)
  • Figure 49. Global Constipation Treatment Drug: by Diseases Type USD Million (2019-2024)
  • Figure 50. Global Constipation Treatment Drug: by Route of administration USD Million (2019-2024)
  • Figure 51. South America Constipation Treatment Drug Share (%), by Country
  • Figure 52. Asia Pacific Constipation Treatment Drug Share (%), by Country
  • Figure 53. Europe Constipation Treatment Drug Share (%), by Country
  • Figure 54. MEA Constipation Treatment Drug Share (%), by Country
  • Figure 55. North America Constipation Treatment Drug Share (%), by Country
  • Figure 56. Global Constipation Treatment Drug: by Type unit (2019-2024)
  • Figure 57. Global Constipation Treatment Drug: by Application unit (2019-2024)
  • Figure 58. Global Constipation Treatment Drug: by Diseases Type unit (2019-2024)
  • Figure 59. Global Constipation Treatment Drug: by Route of administration unit (2019-2024)
  • Figure 60. South America Constipation Treatment Drug Share (%), by Country
  • Figure 61. Asia Pacific Constipation Treatment Drug Share (%), by Country
  • Figure 62. Europe Constipation Treatment Drug Share (%), by Country
  • Figure 63. MEA Constipation Treatment Drug Share (%), by Country
  • Figure 64. North America Constipation Treatment Drug Share (%), by Country
  • Figure 65. Global Constipation Treatment Drug: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • AstraZeneca (United Kingdom)
  • Bayer AG (Germany)
  • Sanofi (France)
  • Sucampo Pharmaceuticals, Inc. (United States)
  • Takeda Pharmaceuticals Company Limited (India)
  • Ironwood Pharmaceuticals, Inc. (United States)
  • Bausch Health (Canada)
  • Abbott Laboratories (United States)
  • Cosmo Pharmaceuticals NV (Ireland)
  • Synergy Pharmaceuticals, Inc. (United States)
Additional players considered in the study are as follows:
Prestige Brands Holdings, Inc. (United States) , Janssen Pharmaceutical Company (Belgium) , Shionogi & Co., Ltd. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation